Aspergillosis: A comprehensive review of pathogenesis, drug resistance, and emerging therapeutics. [PDF]
J Food Drug AnalSingh A, Singh J, Kumar S.
europepmc +1 more source
Elevated carbon dioxide enhances the growth and reduces the antifungal susceptibility of <i>Histoplasma capsulatum</i>. [PDF]
Microbiol SpectrShen Q, Steinmetz K.
europepmc +1 more source
The fluoroquinolone compounds potentiate the antifungal activity of the echinocandins against Aspergillus fumigatus. [PDF]
Biosci RepChoi JJ +8 more
europepmc +1 more source
Comparison of Morphological, Virulence, and Antifungal Susceptibility Characteristics Within <i>Aspergillus Lentulus</i>. [PDF]
Infect Drug ResistWang X +4 more
europepmc +1 more source
Untersuchungen zur Anwendung der Flüssigkeitschromatographie-Tandem-Massenspektrometrie in der medizinischen Laboratoriumsdiagnostik [PDF]
, 2012 Kirchhoff, Fabian
core
The Gcn5 lysine acetyltransferase mediates cell wall remodeling, antifungal drug resistance, and virulence of <i>Candida auris</i>. [PDF]
mSphereChauhan M +6 more
europepmc +1 more source
Caspofungin acetate: An antifungal agent [PDF]
American Journal of Health-System Pharmacy, 2001 The pharmacology, bioavailability and pharmacokinetics, clinical efficacy, and adverse effects of caspofungin acetate are reviewed. Caspofungin acetate is an echinocandin with fungicidal activity against a wide range of pathogens, including Candida spp., Aspergillus spp., and Histoplasma spp.
openaire +4 more sources
Related searches:
Caspofungin is the first in a new class of antifungal agents, the glucan synthesis inhibitors, that interfere with fungal cell wall synthesis. Caspofungin exhibited in vitro and in vivo efficacy against a wide range of fungi and yeasts including Aspergillus and Candida species.
G M, Keating, B, Jarvis
+8 more sources
CASPOFUNGIN FOR CANDIDA ENDOCARDITIS
The Pediatric Infectious Disease Journal, 2004 Michał Wojtalik, Wojciech Mrówczyński
openaire +3 more sources